Literature DB >> 21139071

Cardiomyocyte lipids impair β-adrenergic receptor function via PKC activation.

Konstantinos Drosatos1, Kalyani G Bharadwaj, Anastasios Lymperopoulos, Shota Ikeda, Raffay Khan, Yunying Hu, Rajiv Agarwal, Shuiqing Yu, Hongfeng Jiang, Susan F Steinberg, William S Blaner, Walter J Koch, Ira J Goldberg.   

Abstract

Normal hearts have increased contractility in response to catecholamines. Because several lipids activate PKCs, we hypothesized that excess cellular lipids would inhibit cardiomyocyte responsiveness to adrenergic stimuli. Cardiomyocytes treated with saturated free fatty acids, ceramide, and diacylglycerol had reduced cellular cAMP response to isoproterenol. This was associated with increased PKC activation and reduction of β-adrenergic receptor (β-AR) density. Pharmacological and genetic PKC inhibition prevented both palmitate-induced β-AR insensitivity and the accompanying reduction in cell surface β-ARs. Mice with excess lipid uptake due to either cardiac-specific overexpression of anchored lipoprotein lipase, PPARγ, or acyl-CoA synthetase-1 or high-fat diet showed reduced inotropic responsiveness to dobutamine. This was associated with activation of protein kinase C (PKC)α or PKCδ. Thus, several lipids that are increased in the setting of lipotoxicity can produce abnormalities in β-AR responsiveness. This can be attributed to PKC activation and reduced β-AR levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21139071      PMCID: PMC3064003          DOI: 10.1152/ajpendo.00569.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  69 in total

1.  Validated comprehensive analytical method for quantification of coenzyme A activated compounds in biological tissues by online solid-phase extraction LC/MS/MS.

Authors:  Christoph Magnes; Maria Suppan; Thomas R Pieber; Tarek Moustafa; Michael Trauner; Guenter Haemmerle; Frank M Sinner
Journal:  Anal Chem       Date:  2008-07-09       Impact factor: 6.986

2.  Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure.

Authors:  Suresh Selvaraj Palaniyandi; Koichi Inagaki; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2008-09-04       Impact factor: 5.000

Review 3.  Creating and curing fatty hearts.

Authors:  Raffay S Khan; Konstaninos Drosatos; Ira J Goldberg
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-03       Impact factor: 4.294

4.  DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity.

Authors:  Li Liu; XiaoJing Shi; Kalyani G Bharadwaj; Shota Ikeda; Haruyo Yamashita; Hiroaki Yagyu; Jean E Schaffer; Yi-Hao Yu; Ira J Goldberg
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

Review 5.  Mitochondrial dysfunction and lipotoxicity.

Authors:  Patrick Schrauwen; Vera Schrauwen-Hinderling; Joris Hoeks; Matthijs K C Hesselink
Journal:  Biochim Biophys Acta       Date:  2009-09-24

6.  Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy.

Authors:  Pedro Geraldes; Junko Hiraoka-Yamamoto; Motonobu Matsumoto; Allen Clermont; Michael Leitges; Andre Marette; Lloyd P Aiello; Timothy S Kern; George L King
Journal:  Nat Med       Date:  2009-11-01       Impact factor: 53.440

7.  Protein kinase Ctheta is required for autophagy in response to stress in the endoplasmic reticulum.

Authors:  Kenjiro Sakaki; Jun Wu; Randal J Kaufman
Journal:  J Biol Chem       Date:  2008-03-20       Impact factor: 5.157

8.  Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.

Authors:  Tae-Sik Park; Yunying Hu; Hye-Lim Noh; Konstantinos Drosatos; Kazue Okajima; Jonathan Buchanan; Joseph Tuinei; Shunichi Homma; Xian-Cheng Jiang; E Dale Abel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2008-05-30       Impact factor: 5.922

9.  Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy.

Authors:  Kim A Connelly; Darren J Kelly; Yuan Zhang; David L Prior; Andrew Advani; Alison J Cox; Kerri Thai; Henry Krum; Richard E Gilbert
Journal:  Circ Heart Fail       Date:  2009-02-10       Impact factor: 8.790

10.  Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.

Authors:  Qinghang Liu; Xiongwen Chen; Scott M Macdonnell; Evangelia G Kranias; John N Lorenz; Michael Leitges; Steven R Houser; Jeffery D Molkentin
Journal:  Circ Res       Date:  2009-06-25       Impact factor: 17.367

View more
  35 in total

1.  Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure.

Authors:  Li Liu; Chad M Trent; Xiang Fang; Ni-Huiping Son; HongFeng Jiang; William S Blaner; Yunying Hu; Yu-Xin Yin; Robert V Farese; Shunichi Homma; Andrew V Turnbull; Jan W Eriksson; Shi-Lian Hu; Henry N Ginsberg; Li-Shin Huang; Ira J Goldberg
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

Review 2.  Metabolism in cardiomyopathy: every substrate matters.

Authors:  Julia Ritterhoff; Rong Tian
Journal:  Cardiovasc Res       Date:  2017-03-15       Impact factor: 10.787

3.  Sequestration of fatty acids in triglycerides prevents endoplasmic reticulum stress in an in vitro model of cardiomyocyte lipotoxicity.

Authors:  Madeleen Bosma; Dianne H Dapito; Zoi Drosatos-Tampakaki; Ni Huiping-Son; Li-Shin Huang; Sander Kersten; Konstantinos Drosatos; Ira J Goldberg
Journal:  Biochim Biophys Acta       Date:  2014-12

4.  Diacylglycerol acyl transferase 1 overexpression detoxifies cardiac lipids in PPARγ transgenic mice.

Authors:  Li Liu; Shuiqing Yu; Raffay S Khan; Shunichi Homma; P Christian Schulze; William S Blaner; Yuxin Yin; Ira J Goldberg
Journal:  J Lipid Res       Date:  2012-05-24       Impact factor: 5.922

Review 5.  Mechanisms of lipotoxicity in the cardiovascular system.

Authors:  Adam R Wende; J David Symons; E Dale Abel
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 6.  Lipid Use and Misuse by the Heart.

Authors:  P Christian Schulze; Konstantinos Drosatos; Ira J Goldberg
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

Review 7.  Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure.

Authors:  Tae-Sik Park; Ira J Goldberg
Journal:  Heart Fail Clin       Date:  2012-08-10       Impact factor: 3.179

8.  Savings precede spending: fatty acid utilization relies on triglyceride formation for cardiac energetics.

Authors:  Konstantinos Drosatos; P Christian Schulze
Journal:  Circulation       Date:  2014-11-11       Impact factor: 29.690

9.  Dual peroxisome-proliferator-activated-receptor-α/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction.

Authors:  Charikleia Kalliora; Ioannis D Kyriazis; Shin-Ichi Oka; Melissa J Lieu; Yujia Yue; Estela Area-Gomez; Christine J Pol; Ying Tian; Wataru Mizushima; Adave Chin; Diego Scerbo; P Christian Schulze; Mete Civelek; Junichi Sadoshima; Muniswamy Madesh; Ira J Goldberg; Konstantinos Drosatos
Journal:  JCI Insight       Date:  2019-08-08

10.  Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload.

Authors:  Aly Elezaby; Aaron L Sverdlov; Vivian H Tu; Kanupriya Soni; Ivan Luptak; Fuzhong Qin; Marc Liesa; Orian S Shirihai; Jamie Rimer; Jean E Schaffer; Wilson S Colucci; Edward J Miller
Journal:  J Mol Cell Cardiol       Date:  2014-12-09       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.